Novo Holdings, the controlling shareholder of Ozempic-maker Novo Nordisk (NVO), nearly doubled its annual income and investment returns in 2024.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump )
Also on site :
- Trump plan for fast-tracking nuclear power takes aim at regulators
- Freedom of the Press Foundation Threatens Legal Action if Paramount Settles With Trump Over '60 Minutes' Interview
- Lithium Iron Phosphate Batteries Drive Market Boom